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Recent observations have shown that metacyclic trypomastigotes from culture are 
readily  ingested  by  resident  mouse  macrophages,  subsequently  escape  from  the 
endocytic  vacuole,  and  replicate  in  the  cytoplasm  (1).  In  contrast,  macrophages 
activated in vivo (2) or exposed to lymphokines in vitro (3) are capable of destroying 
ingested  metacyclic forms. This response  is associated  with  the production  of H202 
and perhaps other O2 intermediates  (4). 
Our studies  have now focused on the blood  form trypomastigotes  (BFT)  isolated 
from infected mice. These organisms differ from metacyclic trypomastigotes in being 
more virulent for experimental  animals, having a  thick surface coat and exhibiting a 
characteristic S-shaped appearance. In this communication we demonstrate that BFT 
of both  the CL and  Y  strains  of T~ypanosoma cruzz resist  ingestion  by mouse macro- 
phages.  An  antiphagocytic  substance  can  be  removed  from  their  surface  by  brief 
trypsin digestion, and this treatment, as well as opsonization with antibody, promotes 
ingestion without modifying their intracellular fate in resident or inflammatory mouse 
macrophages. 
Materials  and Methods 
Parasztes.  The Y and CL strains of T. cruzt were obtained from Dr. R. Nussenzweig (New 
York University School of Medicine, New York). Parasites were maintained by weekly transfers 
in  18-  to 20-g male A/J  mice  (The Jackson  Laboratories,  Bar  Harbor,  Maine).  BFT were 
obtained  from  7-d-infected  mice and  isolated  by  density  centrifugation  on  a  FieolI-Paque 
column (Pharmaeia Fine Chemicals, Div. of Pharmacia, Ine, Piscataway, N  J ). Blood from 
infected mice was diluted  1:1 with phosphate-buffered saline (PBS)  (Grand Island Biological 
Co., Grand Island, N. Y.) and trypomastigotes recovered at the interface between plasma and 
the Ficoll-Paque with other slowly sedimenting particles (platelets and a few lymphocytes and 
monocytes). Cells were then washed once at 400 g for I0 min and subsequently at  150 g for 10 
min to remove platelets. With this procedure erythrocyte-free trypomasugotes were obtained in 
high yield.  Metaeyelic trypomastigotes were purified as previously described (3). 
Macrophages.  Normal mouse peritoneal macrophages were obtained from female Swiss mice 
maintained at The Rockefeller Umversity (New York)  Cells were harvested according to the 
methods of Cohn and Benson (5) and cultivated on  13-mm, round, glass covershps in  16-mm 
Linbro plates (Linbro Chemical Co, New Haven, Conn.) in Dulbecco's medium (Grand Island 
Biological  Co)  that contained  10% heat-reactivated  fetal bovine serum  (FBS)  (Grand Island 
Biological  Co),  100 U/ml penicillin,  and  100 #g/ml streptomycin (DI0 FBS)  Inflammatory 
macrophages were obtained from female Swiss mice injected intraperitoneally 4 d earlier with 
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1 ml of a  1% solution of proteose-peptone (Difco Laboratories, Detroit, Mich.)  Macrophages 
were harvested and cultivated as described above. 
Lymphokme-actwated Macrophages.  Normal resident peritoneal macrophages were exposed 2 h 
after explanting to D10 FBS that contained 25%  T  cruzz-induced lymphokine or 25% control 
lymphokine, as previously described (3) 
Trypsm,zatton of Paras,tes.  Blood form or metacychc trypomastigotes were washed once in 
Hanks' balanced salt solution (HBSS) (Grand Island Biological Co.) and incubated in 500/~g/ 
ml  of  trypsin  (type  III  from  bovine  pancreas  that  was  twice  crystallized, dialyzed,  and 
lyophilized; Sigma Ghemmal Co., St. Louis, Mo.) in Dulbecco's medium for 15 min at 37°C. 
Trypsinization was stopped by the addition of 30% heat-inactivated FBS. The parasites were 
washed once in HBSS and resuspended to the desired concentration in Dulbecco's medium 
Hyper,  mmune Serum  Hyperimmune serum was obtained by immunizmg mice with 5 ×  106 
live culture forms of CL or Y strains of T. cruet in PBS. Animals were then injected four times 
at  15-d  intervals with  105 live BFT  Blood was collected 1 wk after-the last injection, serum 
prepared and then stored at -70°C.  Such sera have a  preponderance of IgG antibody (6)  A 
1:4 dilution of heat-snactivated opsomzing serum  in  Dulbecco's medium  was  added to  the 
purified parasites and  maintained in  the macrophage cultures throughout  the 3-h infection 
period. 
Infection of Cells and  Evaluatzon of Macrophage T~ypanoczdal Actwlty.  Infection  of cells  and 
evaluation of maerophage trypanocidal activity was performed according to methods previously 
described (1). 
Blocking ofMacrophage Fc Receptor.  24-h explanted macrophages were washed three times in 
HBSS  and  incubated for 30  min  at  4°G with  30 pg/ml  in  PBS  of 2 4 G2.  This is an  IgG 
monoclonal antibody against the mouse Fc receptor (7) and was kindly provided by Dr. Jay 
Unkeless (The Rockefeller University). Cells were then washed once m  HBSS and exposed for 
3 h to a suspension of parasites that contained the same concentration of anu-Fc antibody 
Results 
The Interactzon of Macrophages wah BFT.  The exposure of resident macrophages to 
large  numbers  of  BF-I"  of either  the  CL  or  Y  strains  lead  to  the  ingestion  and 
parasitization of <3%  of the  cells. The  multiplicities employed  (1'2  and  1:3)  were 
sufficient  to  infect  >35%  of the  similar cells with  metacyclic  forms.  This  striking 
difference in  uptake suggested the presence of a  potent  antiphagocytic material on 
the  surface  of BFT.  This  possibility was  first  explored  by  modifying  the  parasite 
surface  with  proteases.  Brief trypsin  treatment  of BFT  (15  min,  500  ~g/ml)  and 
enzyme inactivation with heat-inactivated fetal calf serum was accomplished without 
modification of parasite motility or viability. The addition of trypsinized organisms 
to macrophages  (Table I)  lead to a  10-fold enhancement  in the entry of organisms 
This effect was unrelated to the presence of serum per se.  Both the CL and Y  strain 
TABLE  I 
Effect of Trypsm Treatment on the Uptake of BFT of T  cruzz by Mouse Peritoneal 
Macrophages 
Treatment of para-  Percentage of  Per,._entage  of  Para,,ite',/100 
Stram  ,,ite,,  infected mac-  infected mac- 
rophages at  ~  rophages at  72  macrophages 
at  72 h 
Tryp,,m  Serum  h  h 
CL  -  -  2 5  2  3  ~0 
+  -  2h  25  ~88 
Y  -  -  2  5  3  5  20 
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behaved in a similar fashion, whereas metacyclic trypomastigotes were unaffected by 
trypsinization. 
The Ad&tive Roles of T~ypsin and Hyperimmune Serum.  The  trypsin  digestion  of the 
parasite surface still allowed the expression of opsonizing antibody (Table II). In fact, 
opsonization with antibody has an additive effect on trypsin-treated  parasites at the 
high  parasite:cell  ratios  employed.  It  also  promoted  the  uptake  of nontrypsinized 
parasites.  This  effect  was  seen  with  both  fresh  and  heat-inactivated  serum  and 
occurred only if the concentration  of specific antiserum was maintained  throughout 
the entire infection period. The effect of hyperimmune serum in enhancing ingestion 
was mediated via the Fc receptor on the macrophage surface. Table II illustrates that 
treatment of macrophages with a monoclonal antibody against the Fc receptor II (7) 
blocked the uptake of previously opsonized BFT but did not influence cell parasiti- 
zation with trypsin-digested organisms. Similar information was obtained with the Y 
strain. 
The  Fate of BFT  Within  Restdent and Acttvated  Macrophages.  Because  it  was  now 
possible to parasitize macrophages  in vitro with BFT, it was next of importance  to 
examine their intracellular fate. Neither trypsin nor hyperimmune serum influenced 
parasite  viability  in  either  resident  or  inflammatory  macrophages,  and,  by  72  h, 
extensive replication of the CL and Y strains had occurred. In contrast, when taken 
up by activated macrophages (lymphokine induced) the vast majority of the organisms 
were  promptly  destroyed  (Table  III).  In  fact,  in  vitro  activated  macrophages 
TABLE II 
Effect of Hypenmmune Serum and T~yps,n on the Uptake and Fate of BFT* by Mouse Per+toneal 
Macrophages 
Macrophage  Treatment of para-  Percentage of 
sites  Parasttes/100 macro-  Parasltes/ll)O  infected  mac- 
treatment  with  phage,, at 3  h  macrophages at 
antt-Fc  antibody  Trypsin  Serum  72 h  rophage,h at  72 
'7, 
None  -  -  Undetect able  15  1 
2 4 G2  -  -  Undetectable  4  5  0  5 
None  -  +  35  230  20 
2 4  G2  -  +  Undetectable  7  1 5 
None  +  -  18  130  9 
2 4 G2  +  -  14  102  8 
None  +  +  58  344  38 
24G2  +  +  17  97  95 
* CL Stram 
TAnLE  III 
Fate of T~psmzzed  and Opsomzed BFT of T. cruzt m Macrophage Populattons 
Treatment of macrophages 
Treatment of para-  Paras,tes/100 
~.~t~ 
macrophages at 
Trypsin  Serum  72 h 
Percentage of 
m fected  mac- 
rophages at 
72 h 
+7, 
Medmm alone  +  -  231  26 
Medium plus lymphokme  +  -  40  11 
Medium plus control supernate  +  -  269  25 
Medmm alone  +  +  558  54 
Medmrn  plus lymphokme  +  +  0  0 
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appear to kill serum-opsonized blood forms to a  greater extent than nonopsonized 
organisms. 
Discussion 
These experiments indicate that  BFT obtained from mice acutely infected with 
either the Y or CL strain, which, under normal conditions, resist in vitro uptake by 
macrophages, can be rendered susceptible to phagocytosis. This can be accomplished 
either by mild proteolysis with trypsin and/or opsonization with hyperimmune mouse 
serum. This suggests the presence of an antiphagocytic factor on the blood forms that 
is not demonstrable in the metacyclic trypomastigotes propagated in acellular cultures. 
The enhanced ingestion of BFT after treatment with trypsin and hyperimmune 
serum appears to occur by separate mechanisms. Hyperimmune serum and, presum- 
ably, its content of IgG antibody opsonizes the organisms in a classical fashion, and 
binding and interiorization take place via the Fc receptor. Therefore, a  monoclonal 
antibody (2.4.G2)  directed against this receptor effectively negates any opsonizing 
effect. Trypsin, on the other hand, appears to be removing an antiphagocytic factor 
and promoting ingestion via a non-Fc-mediated mechanism. This may represent the 
previously described protease-sensitive macrophage receptor that modulates the up- 
take  of culture  form  trypomastigotes  (1).  Both  trypsin  and  hyperimmune serum 
combine to mutually enhance parasite uptake in an additive fashion. 
The antiphagocytic factor is found not only in the CL strain of T. cruzt, reported to 
be a myotropic strain and unable to enter macrophages (8), but also in the Y strain, 
considered to preferentially parasitize macrophages. We predict that some of the in 
vitro  differences observed  between  these  strains  (9)  may be  abolished  by  trypsin 
digestion.  Once  taken  up  by  macrophages  in  vitro  the  BFT  behave  in  a  fashion 
identical to the cultured trypomastigotes. That is, the organisms proliferate within 
the  resident  or  inflammatory macrophage  and  are  destroyed  in  the  lymphokine- 
activated cell. The consistent effect of hyperimmune serum in enhancing the destruc- 
tion of BFT in activated macrophages is of interest.  Possibly, antibody coating the 
parasites modifies its escape  from the vacuolar system in a  fashion similar to  that 
described  for vaccinia virus  (10).  In  any  event,  it  represents  another  example of 
combined humoral and cell-mediated immunity and deserves more careful scrutiny. 
As opposed to prior descriptions (8), we found no difference in the fate of opsonized 
parasites of either strain in normal macrophages. In contrast, opsonization enhanced 
their killing by activated  macrophages,  despite  the  increase  in  their  uptake.  This 
suggests that the role of antibody in vivo may be dependent upon the presence of 
active cell-mediated immunity. This could explain some of the controversies surround- 
ing the protective effects of passively transferred immune serum (6). 
The relevance of these findings to other in vivo events in both animals and man 
remains to be explored. It seems possible, however, that through immunophagocytosis 
one could remove organisms from the blood stream and focus them into mononuclear 
phagocytes that at least have the potential for destroying them. This might prevent 
the  persistent  parasitization  of other  organs,  such  as  the  heart,  and  the  possible 
sequellae of chronic trypanosonemia. 
We have considered that the antiphagocytic substance may either be a component 
of host origin that coats the parasite preventing uptake, or a parasite product that is 
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blood  and  culture  forms  by  means  of enzymatic  iodination  should  answer  these 
questions and will form the subject of a  future communication. 
Summary 
Blood form trypomastigotes of the Y and CL strains of T~ypanosorna cruzi were tested 
for their ability to enter and infect mouse peritoneal macrophages. Both strains failed 
to enter macrophages in  appreciable numbers,  whereas  metacyclic trypomastigotes 
purified from acellular cultures were ingested with ease. Macrophage parasitization 
was enhanced manyfold after the removal of an antiphagocytic substance by trypsin- 
ization. This occurred without modification of parasite viability. Opsonization with 
hyperimmune mouse serum also enhanced the uptake of blood form trypomastigotes 
by macrophages. This effect was mediated by the macrophage Fc receptor. The effects 
of serum and trypsinization were additive at high parasite:cell ratios. Neither trypsin- 
mediated nor antibody-dependent opsonization of the organisms modified the fate of 
either  strain  within  resident  macrophages.  However, lymphokine-activated macro- 
phages were capable of destroying both strains,  and antibody opsonization  further 
enhanced this process. 
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